国际皮肤性病学杂志    2003 29 (5): 276-278   ISSN: 2096-5540  CN: 32-1880/R   神经肽Y与白癜风相关的研究进展 马慧军, 朱文元 南京医科大学第一附属医院皮肤科 南京 210029 收稿日期 2002-11-12  修回日期 null  网络版发布日期 null 参考文献  [1] Renshaw D,Hinson JP.Neuropeptide Y and the adrenal gland:a review.Peptides,2001,22(3):429-438. [2] Balasubramaniam A.Clinical potentials of neuropeptide Y family of hormones.Am J Surg,2002,183(4):430-434. [3] Galas L,Tonon MC,Beaujean D,et al.Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone(alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells.Endocrinology,2002,143(5):1686-1694. [4] Al'Abadie MS,Senior HJ,Bleehen SS,et al.Neuropeptide and neuronal marker studies in vitiligo.Br J Dermatol,1994,131(2):160. [5] Liu PY,Bondesson L,Lontz W,et al.The occurrence of cutaneous nerve endings and neuropeptides in vitiligo vulgaris:a case-control study.Arch Dermatol Res,1996,288(11):670-675. [6] Lazarova R,Hristakieva E,Lazarov N,et al.Vitiligo-related neuropeptides in nerve fibers of the skin.Arch Physiol Biochem,2000,108(3):262-267. [7] Hristakieva E,Lazarova R,Lazarov N,et al.Markers for vitiligo related neuropeptides in human skin nerve fibers.Acta Med Croatica,2000,54(2):53-57. [8] Tu C,Zhao D,Lin X.Levels of neuropeptide-Y in the plasma and skin tissue fluids of patients with vitiligo.J Dermatol Sci,2001,27(3):178-182. [9] Lazarova R,Hristakieva E,Lazarov N,et al.Vitiligo-related neuropeptides in nerve fibers of the skin.Arch Physiol Biochem,2000,108(3):262-267. [10] Misery L.Skin,immunity and the nervous system.Br J Dermatol,1997,137(6):843-850. [11] Friedman EM,Irwin MR.Modulation of immune cell function by the autonomic nervous system.Pharmacol Ther,1997,74(1):27-38. [12] Levite M.Neuropeptides,by direct interaction with T cells,induce cytokine secretion and break the commitment to a distinct T helper phenotype.Proc Natl Acad Sci U S A,1998,95(21):12544. [13] Abdel-Naser MB,Kruger-Krasagakes S,Krasagakis K,et al.Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo.Pigment Cell Res,1994,7(1):1-8. [14] Tu CX,Fu HW,Lin XR.Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo.J Dermatol Sci,1999,21(1):59-62. [15] Al'Abadie MS,Warren MA,Bleehen SS,et al.Morphologic observations on the dermal nerves in vitiligo:an ultrastructural study.Int J Dermatol,1995,34(12):837-840. [16] Hara M,Toyoda M,Yaar M,et al.Innervation of melanocytes in human skin.J Exp Med,1996,184(4):1385-1395. [17] Hernanz A,Tato E,De la Fuente M,et al.Differential effects of gastrin-releasing peptide,neuropeptide Y,somatostatin and vasoactive intestinal peptide on interleukin-1 beta,interleukin-6 and tumor necrosis factor-alpha production by whole blood cells from healthy young and old subjects.J Neuroimmunol,1996,71(1-2):25-30. [18] Krasagakis K,Garbe C,Eberle J,et al.Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitro.Arch Dermatol Res,1995,287(3-4):259-265. [19] Tsatmali M,Ancans J,Thody AJ.Melanocyte function and its control by melanocortin peptides.J Histochem Cytochem,2002,50(2):125. [20] Galas L,Tonon MC,Beaujean D,et al.Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone(alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells.Endocrinology,2002,143(5):1686-1694. 通讯作者: